Cargando…
Entry of the antipsychotic drug, olanzapine, into the developing rat brain in mono- and combination therapies
Background: Olanzapine is used to treat schizophrenia and bipolar disorder in women of childbearing age. Continuation of psychotropic medications throughout pregnancy and lactation is often required as cessation could be dangerous for both mother and child. However, there is a lack of information on...
Autores principales: | Huang, Yifan, Qiu, Fiona, Habgood, Mark, Nie, Shuai, Dziegielewska, Katarzyna, Saunders, Norman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925881/ https://www.ncbi.nlm.nih.gov/pubmed/36798113 http://dx.doi.org/10.12688/f1000research.128074.2 |
Ejemplares similares
-
Entry of antiepileptic drugs (valproate and lamotrigine) into the developing rat brain
por: Toll, Samuel J., et al.
Publicado: (2021) -
Determinants of drug entry into the developing brain
por: Koehn, Liam, et al.
Publicado: (2019) -
Age dependent contribution of entry via the CSF to the overall brain entry of small and large hydrophilic markers
por: Qiu, Fiona, et al.
Publicado: (2022) -
Lithium administered to pregnant, lactating and neonatal rats: entry into developing brain
por: Chiou, Shene Yi-Shiuan, et al.
Publicado: (2021) -
Developmental changes in the extent of drug binding to rat plasma proteins
por: Qiu, Fiona, et al.
Publicado: (2023)